Tranexamic Acid-13C2,15N – 1 mg

Brand:
Cayman
CAS:
1292837-95-6
Storage:
-20
UN-No:
Non-Hazardous - /

Tranexamic acid 13C2,15N is intended for use as an internal standard for the quantification of tranexamic acid (Item No. 19193) by GC- or LC-MS. Tranexamic acid is an inhibitor of fibrinolysis that inhibits the interaction of plasmin with fibrin (IC50 = 3.1 µM in isolated human plasma).{31118} It reduces increases in the expression of the profibrogenic genes Timp1 and Col1a1, but not Itgb6, Tgfβ1, or Tgfβ2, and increases in hepatic protein levels of cytokeratin 19 (CK19) and type I collagen induced by α-naphthylisothiocyanate (AINT) after 28 days in a mouse model of chronic bile duct injury.{45512}  

 

Available on backorder

SKU: 28804 - 1 mg Category:

Description

An internal standard for the quantification of tranexamic acid by GC- or LC-MS


Formal name: trans-4-(amino-15N-methyl-13C)-cyclohexanecarboxylic-13C acid

Synonyms:  AMCA-13C2,15N|TXA-13C2,15N

Molecular weight: 160.2

CAS: 1292837-95-6

Purity: ≥95%

Formulation: A solid